Pharmaceutical Intermediates Market: Investments in Manufacturing to Ascend: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029
- REP-GB-4515
- 2019-04-26
- Category: Healthcare, Pharmaceuticals and Medical devices
- 275 Pages
- Format:
Pharmaceutical Intermediates Market - Key Research Findings
-
Global pharmaceutical intermediates market size in 2018 – Over US$ 26,800 Mn
-
The pharmaceutical intermediates market is envisaged to witness moderate expansion at an estimated 4.4% CAGR, over 2019-2029.
-
East Asia and North America are expected to remain high-growth regional markets for pharmaceutical intermediates.
-
East Asia and North America are the leading regions in the pharmaceutical intermediates market, owing to the high number of the pharmaceutical raw material contract manufacturing companies in the region.
-
Increase in the number of mergers and acquisitions is expected to boost the pharmaceutical intermediates market.
-
A majority of active operators in the pharmaceutical intermediates market are opting for strategic mergers and acquisitions.
-
The specialty contract manufacturing companies are being acquired by final drug formulation manufacturing companies to keep up with their requirement of the pharmaceutical intermediates and APIs (active pharmaceutical ingredients).
-
Pharmaceutical intermediates market is observing a growing trend of M&A, subsequently reducing demand- supply gap of the various APIs available on market.
-
Bulk drug intermediates segment are slated to remain an attractive segment in the global pharmaceutical intermediates market.
-
Increasing demand for the chiral intermediates compared to achiral intermediates is the prominent driver, boosting pharmaceutical intermediates market revenues.
-
Soaring consumption of chiral active intermediates is attributed to superiority of chiral intermediates over achiral bulk drug intermediates.
Top 3 Factors Shaping the Pharmaceutical Intermediates Market
-
Increasing Production of Final Drug Formulations
Increasing demand of various pharmaceutical intermediates and APIs owing to increasing production of the final drug formulation is expected to fuel the growth of the market. Globally, various manufacturing companies from the pharma and biopharma industries are focusing on improving their geographical product footprint.
Manufacturers are also focusing enhancing their product reach through various distribution channels in different countries, which is resulting in the massive hike in production capacity.
In January 2019, Fujifilm announced plans to boost the overall production capacity with the North Carolina facility expansion. During 2015-2017, there were more than 130 mergers and acquisitions in the pharma industry, prominently involving contract manufacturing organisations with operations in APIs and pharmaceutical intermediates.
-
Increasing Chronic Disease Prevalence
The rapidly increasing prevalence of chronic diseases and brisk expansion of geriatric population are among the key factors pushing the need for drug formulations for the management of chronic diseases, worldwide. For example, according to the World Health Organization (WHO), the prevalence of diabetes has surged from 108.0 million in 1980 to 422.0 million in 2014, and the number is rising rapidly. Moreover, WHO also states that the prevalence of chronic diseases will possibly increase by 57% by 2020, clearly indicating a possibility of a significant percentage of population to suffer from chronic diseases.
-
Increasing Manufacturing Investments
Leading pharmaceutical companies in pharmaceutical intermediates market have announced investments in manufacturing facilities to cater to the growing demand for high production capacity of pharmaceutical intermediates, reduced corporate tax rate (due to recent tax reforms in the US), and a firmer global footprint. The companies are also taking strong efforts in strengthening their presence in emerging markets.
For example, in July 2018, Pfizer announced its plan to invest around US$ 465.0 million to build a sterile injectable plant in Portage, Michigan. This step is a part of its announcement that it had made earlier in 2018 about its plans to invest around US$ 5.0 billion in a US-based capital project due to the recent corporate tax reforms in the country
Pharmaceutical Intermediates Market Structure Analysis
-
The global Pharmaceutical Intermediates market is categorized by small independent companies.
-
Besides production facility expansion, a majority of leading companies are focusing on the increasing their product portfolio offering by offering different types pharmaceutical intermediates.
-
The pharmaceutical intermediates market is a fragmented landscape and several manufacturing companies are based in the East Asia and South Asia regions owing to relatively lower production costs when compared to developed regions.
FMI has compiled a study on the pharmaceutical intermediates market, which offers an analysis and forecast of the Pharmaceutical Intermediates market in its publication titled ‘Pharmaceutical Intermediates Market: Global Industry Analysis 2014 – 2018 and Opportunity Assessment 2019 – 2029.’ This report on the Pharmaceutical intermediates market covers some of the key influencing factors on the demand and supply of Pharmaceutical Intermediates over the next several years. An in-depth review of the growth drivers, potential challenges, unique trends, and opportunities for the market participants is expected to equip readers to fully comprehend the overall landscape of the Pharmaceutical Intermediates market.
The report on the pharmaceutical intermediates market also covers an analysis of the key regions and countries of particular interest, which are estimated to become frontrunners or remain laggards over the forecast period. The report covers a historical analysis of the market from 2014 to 2018, and provides forecasts from 2019 to 2029 in terms of revenue in US$.
Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. There are different types of pharmaceutical intermediates and demand of each type of the pharmaceutical intermediates is high due to increasing pharmaceutical and biopharmaceutical production.
This report on the pharmaceutical intermediates market has been broken down into different chapters to enhance clarity and provide context. A brief executive summary at the beginning of the report consists of some of the key findings of the study on the pharmaceutical intermediates market, as well as market estimates and growth rates for important segments. The following chapter presents the definitions and scope of the study, as well as the coverage in terms of the way in which the pharmaceutical intermediates market is structured.
Subsequently, the chapter on the market background contains relevant economic indicators, such as per capita healthcare spending and increase in cancer cases, which elaborate the dynamics impacting the pharmaceutical intermediates market, as well as provides an explanation of the factors considered important to develop forecasts and estimates. The following chapters dive deep into the global pharmaceutical intermediates market, covering detailed information based on product type, application and end user. The next set of chapters provide a region-wise analysis and forecasts of the pharmaceutical intermediates market, which cover the vital aspects of the market in North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
A dashboard view of some of the key companies operating in the pharmaceutical intermediates market in terms of their offerings, regional presence, and other metrics is a precursor to the detailed profiles of these participants, which include their financial information, strategy overview, and products offered, SWOT analysis as well as analyst commentary. Some of the key players analyzed in the Pharmaceutical Intermediates market report include Chiracon GmbH, Aceto Corporation, Midas Pharma GmbH, BASF SE, Codexis, Inc., A.R. Life Sciences Private Limited, Dishman Group, ZCL Chemicals Ltd., Pfizer, Inc., Arkema Inc and Cambrex Corporation among others.
To develop the estimates for the pharmaceutical intermediates market, the global adoption/consumption of pharmaceutical intermediates was taken into account, which was followed by tracking key players and their product offering globally. This is then cross-referenced with the revenue generated from the sales of pharmaceutical intermediates for top companies globally.
Our team of analysts reviews and interpret data from a variety of sources. The data attributed to ‘FMI’ is derived by using a combination of various approaches, which are then consolidated, interpreted, and extrapolated by FMI analysts. Data is sourced from government statistics, trade associations, company annual reports, investor presentations, press articles & directories, technical publications, and online databases, which are cross-referenced with FMI’s reports and internal repository of data to filter and validate the collected information.
The intelligence gathered from desk research is supplemented by extensive interviews with selected key expert participants across the value chain not only to gain information specific to their role and operations, but also to obtain their perspective and insights of the issues impacting the pharmaceutical intermediates market.
Global Pharmaceutical Intermediates Market: Segmentation
Analysis by Product Type
-
Chemical Intermediates
-
Bulk Drug Intermediates
-
Chiral Intermediates
-
Achiral Intermediates
-
-
Custom Intermediates
Analysis by Category
-
Branded Drug Intermediates
-
Generic Drug Intermediates
Analysis by Application/Drug Type
-
Analgesics
-
Anti-Infective Drugs
-
Cardiovascular Drugs
-
Oral Antidiabetic Drugs
-
Antimicrobial Drugs
-
Others
Analysis by End User
-
Biotech & Pharma Companies
-
Research Laboratories
-
CMOs/CROs
Analysis by Region
-
North America
-
Latin America
-
Europe
-
East Asia
-
South Asia
-
Oceania
-
Middle East & Africa
Pharmaceutical Intermediates Market Reports - Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic Promotional Activities, By Key Manufacturers
5. Global Pharmaceutical Intermediates Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Increasing Healthcare R & D Spending
6.1.2. Emergence of Academia as the Primary Organisation for Carrying Out Basic Research
6.2. Forecast Factors - Relevance & Impact
6.2.1. Prevalence of Chronic Diseases
6.2.2. Increased Government Focus on Generic Drugs
6.2.3. Growing Demand for Biologics and Specialty Drugs
6.2.4. Production Capacity Growth
6.2.5. Top Companies Historic Average Growth
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 - 2017
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2018 - 2018
7.3.1. Chemical Intermediates
7.3.2. Bulk Drug Intermediates
7.3.2.1. Chiral Intermediates
7.3.2.2. Achiral Intermediates
7.3.3. Custom Intermediates
7.4. Market Attractiveness Analysis By Product Type
8. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Category
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Category, 2013 - 2017
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Category, 2018 - 2018
8.3.1. Branded Drug Intermediates
8.3.2. Generic Drug Intermediates
8.4. Market Attractiveness Analysis By Category
9. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2013 - 2017
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2018 - 2018
9.3.1. Analgesics
9.3.2. Anti-Infective Drugs
9.3.3. Cardiovascular Drugs
9.3.4. Oral Antidiabetic Drugs
9.3.5. Antimicrobial Drugs
9.3.6. Others
9.4. Market Attractiveness Analysis By Application
10. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2013 - 2017
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2018 - 2018
10.3.1. Biotech & Pharma Companies
10.3.2. Research Laboratories
10.3.3. CMOs/CROs
10.4. Market Attractiveness Analysis By End User
11. Global Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2017
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Middle East and Africa (MEA)
11.3.5. East Asia
11.3.6. South Asia
11.3.7. Oceania
11.4. Market Attractiveness Analysis By Region
12. North America Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Category
12.3.4. By Application
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product Type
12.4.3. By Category
12.4.4. By Application
12.4.5. By End User
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Latin America Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Category
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Category
13.4.4. By Application
13.4.5. By End User
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Europe Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. France
14.3.1.3. Italy
14.3.1.4. U.K.
14.3.1.5. BENELUX
14.3.1.6. Russia
14.3.1.7. Rest of Europe
14.3.2. By Product Type
14.3.3. By Category
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Category
14.4.4. By Application
14.4.5. By End User
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Category
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Category
15.4.4. By Application
15.4.5. By End User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Category
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Category
16.4.4. By Application
16.4.5. By End User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Oceania Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Category
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Category
17.4.4. By Application
17.4.5. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. South Africa
18.3.1.3. North Africa
18.3.1.4. Turkey
18.3.1.5. Rest of MEA
18.3.2. By Product Type
18.3.3. By Category
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Category
18.4.4. By Application
18.4.5. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Emerging Countries Pharmaceutical Intermediates Market Analysis 2014-2018 and Forecast 2019-2029
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. China Pharmaceutical Intermediates Market Analysis
19.2.1. Introduction
19.2.2. PEST Analysis
19.2.3. Market Value Proportion Analysis by Market Taxonomy
19.2.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.2.4.1. By Product Type
19.2.4.2. By Category
19.2.4.3. By Application
19.2.4.4. By End User
19.2.5. China Pharmaceutical Intermediates Market - Competition Landscape
19.2.6. China - Trade Analysis
19.3. India Pharmaceutical Intermediates Market Analysis
19.3.1. Introduction
19.3.2. PEST Analysis
19.3.3. Market Value Proportion Analysis by Market Taxonomy
19.3.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.3.4.1. By Product Type
19.3.4.2. By Category
19.3.4.3. By Application
19.3.4.4. By End User
19.3.5. India Pharmaceutical Intermediates Market - Competition Landscape
19.4. Russia Pharmaceutical Intermediates Market Analysis
19.4.1. Introduction
19.4.2. PEST Analysis
19.4.3. Market Value Proportion Analysis by Market Taxonomy
19.4.4. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.4.4.1. By Product Type
19.4.4.2. By Category
19.4.4.3. By Application
19.4.4.4. By End User
19.4.5. Russia Pharmaceutical Intermediates Market - Competition Landscape
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies (Pharmaceutical Intermediates)
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product foot print by Players
20.4.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Chiracon GmbH
21.3.1.1. Company Overview
21.3.1.2. Analyst Commentary
21.3.1.3. Financial Analysis
21.3.1.4. Product Portfolio
21.3.1.5. Profitability by Market Segments (Product and Region)
21.3.1.6. Sales Footprint
21.3.1.7. Strategy Overview
21.3.1.7.1. Marketing Strategy
21.3.1.7.2. Product Strategy
21.3.1.7.3. Channel Strategy
21.3.2. Aceto Corporation
21.3.3. Midas Pharma GmbH
21.3.4. Codexis, Inc.
21.3.5. Lianhetech
21.3.6. BASF SE
21.3.7. Vertellus Holdings LLC
21.3.8. Sanofi Winthrop Industrie S.A.
21.3.9. A.R. Life Sciences Private Limited
21.3.10. Dishman Group
21.3.11. Chemcon Specialty Chemical Pvt. Ltd.
21.3.12. Dextra Laboratories Limited
21.3.13. ZCL Chemicals Ltd.
21.3.14. Easter Chemical Corporation
21.3.15. Pfizer, Inc.
21.3.16. Bristol-Myers Squibb Company
21.3.17. Arkema Inc.
21.3.18. Interchem
21.3.19. Cambrex Corporation
22. Assumptions and Acronyms Used
23. Research Methodology
Pharmaceutical Intermediates Market Reports - List of Tables
List Of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 04: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 05: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 06: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 07: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Table 08: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 09: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 10: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 11: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 12: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 13: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 14: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 15: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 16: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 17: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 18: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 19: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 20: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 21: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 22: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 23: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 24: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 25: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 26: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 27: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 28: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 29: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 30: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 31: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 32: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 33: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 34: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 35: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 36: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 37: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 38: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 39: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 40: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 41: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 42: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 43: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 44: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 45: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 46: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 47: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 48: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 49: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 50: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 51: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 52: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Table 53: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Table 54: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Pharmaceutical Intermediates Market Reports - List of Figures
List Of Figures
Figure 01: Global Pharmaceutical Intermediates Market Share, By Product Type (2018)
Figure 02: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 03: Global Pharmaceutical Intermediates Market Share, By Category (2018)
Figure 04: Global Pharmaceutical Intermediates Market Share, By Application (2018)
Figure 05: Global Pharmaceutical Intermediates Market Share, By End User (2018)
Figure 06: Global Pharmaceutical Intermediates Market Share, By Region (2018)
Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 08: Global Pharmaceutical Intermediates Historical Market Size and Y-o-Y, 2014-2018
Figure 09: Global Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 10: Global Pharmaceutical Intermediates Market Absolute $ Opportunity, 2013–2028
Figure 11: : Global Pharmaceutical Intermediates Market Analysis by Product Type –2019 & 2029
Figure 12: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Figure 13: : Global Pharmaceutical Intermediates Market Analysis by Category –2019 & 2029
Figure 14: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 15: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Category
Figure 16: : Global Pharmaceutical Intermediates Market Analysis by Application –2019 & 2029
Figure 17: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 18: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Application
Figure 19: : Global Pharmaceutical Intermediates Market Analysis by End User –2019 & 2029
Figure 20: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 21: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Figure 22: : Global Pharmaceutical Intermediates Market Analysis by Region –2019 & 2029
Figure 23: Global Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Region, 2019 – 2029
Figure 24: Global Pharmaceutical Intermediates Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Figure 25: North America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 26: North America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 27: : North America Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 28: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 29: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 30: : North America Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 31: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 32: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 33: : North America Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 34: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 35: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 36: : North America Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 37: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 38: North America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 39: : North America Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 40: North America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 41: North America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 42: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 43: Latin America Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 44: : Latin America Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 45: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 46: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 47: : Latin America Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 48: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 49: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 50: : Latin America Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 51: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 52: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 53: : Latin America Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 54: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 55: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 56: : Latin America Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 57: Latin America Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 58: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 59: Europe Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 60: Europe Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 61: : Europe Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 62: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 63: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 64: : Europe Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 65: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 66: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 67: : Europe Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 68: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 69: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 70: : Europe Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 71: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 72: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 73: : Europe Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 74: Europe Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 75: Europe Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 76: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 77: South Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 78: : South Asia Pharmaceutical Intermediates Market Analysis by Country – 2019 & 2029
Figure 79: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 80: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 81: : South Asia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 82: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 83: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 84: : South Asia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 85: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 86: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 87: : South Asia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 88: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 89: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 90: : South Asia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 91: South Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 92: South Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 93: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 94: East Asia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 95: : East Asia Pharmaceutical Intermediates Market Analysis by Country–2019 & 2029
Figure 96: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 97: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 98: : East Asia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 99: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 100: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 101: : East Asia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 102: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 103: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 104: : East Asia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 105: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 106: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 107: : East Asia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 108: East Asia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 109: East Asia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 110: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 111: Oceania Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 112: : Oceania Pharmaceutical Intermediates Market Analysis by Country –2019 & 2029
Figure 113: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 114: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 115: : Oceania Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 116: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 117: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 118: : Oceania Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 119: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 120: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 121: : Oceania Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 122: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 123: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 124: : Oceania Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 125: Oceania Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 126: Oceania Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 127: MEA Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 128: MEA Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 129: : MEA Pharmaceutical Intermediates Market Analysis by Country – 2019 & 2029
Figure 130: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Country, 2019 – 2029
Figure 131: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Country, 2019 – 2029
Figure 132: : MEA Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 133: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 134: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 135: : MEA Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 136: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 137: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 138: : MEA Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 139: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 140: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 141: : MEA Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 142: MEA Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 143: MEA Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 144: China Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 145: China Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 146: : China Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 147: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 148: China Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 149: : China Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 150: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 151: China Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 152: : China Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 153: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 154: China Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 155: : China Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 156: China Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 157: China Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 158: India Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 159: India Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 160: : India Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 161: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 162: India Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 163: : India Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 164: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 165: India Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 166: : India Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 167: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 168: India Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 169: : India Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 170: India Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 171: India Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029
Figure 172: Russia Pharmaceutical Intermediates Market Size (US$ Mn) Analysis, 2014–2018
Figure 173: Russia Pharmaceutical Intermediates Market Size (US$ Mn) & Y-o-Y Growth (%), 2019 – 2029
Figure 174: : Russia Pharmaceutical Intermediates Market Analysis by Product Type–2019 & 2029
Figure 175: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 176: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Product Type, 2019 – 2029
Figure 177: : Russia Pharmaceutical Intermediates Market Analysis by Category – 2019 & 2029
Figure 178: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Category, 2019 – 2029
Figure 179: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Category, 2019 – 2029
Figure 180: : Russia Pharmaceutical Intermediates Market Analysis by Application – 2019 & 2029
Figure 181: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by Application, 2019 – 2029
Figure 182: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by Application, 2019 – 2029
Figure 183: : Russia Pharmaceutical Intermediates Market Analysis by End User – 2019 & 2029
Figure 184: Russia Pharmaceutical Intermediates Market Y-o-Y Growth Projections by End User, 2019 – 2029
Figure 185: Russia Pharmaceutical Intermediates Market Attractiveness Analysis by End User, 2019 – 2029